Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2NN8

Crystal structure of human galectin-3 carbohydrate-recognition domain with lactose bound, at 1.35 angstrom resolution

2NN8 の概要
エントリーDOI10.2210/pdb2nn8/pdb
関連するPDBエントリー2NMN 2NMO
関連するBIRD辞書のPRD_IDPRD_900004 PRD_900008
分子名称Galectin-3, beta-D-galactopyranose-(1-4)-beta-D-glucopyranose, beta-D-galactopyranose-(1-4)-alpha-D-glucopyranose, ... (6 entities in total)
機能のキーワードbeta-sandwich, sugar binding protein
由来する生物種Homo sapiens (human)
タンパク質・核酸の鎖数1
化学式量合計16513.19
構造登録者
Blanchard, H.,Collins, P.M. (登録日: 2006-10-24, 公開日: 2007-03-06, 最終更新日: 2023-10-25)
主引用文献Collins, P.M.,Hidari, K.I.,Blanchard, H.
Slow diffusion of lactose out of galectin-3 crystals monitored by X-ray crystallography: possible implications for ligand-exchange protocols.
Acta Crystallogr.,Sect.D, 63:415-419, 2007
Cited by
PubMed Abstract: Galectin-3 is a multifunctional carbohydrate-binding protein that has roles in cancer progression. In addition to carbohydrate-dependent extracellular functions, galectin-3 participates in carbohydrate-independent intracellular signalling pathways, including apoptosis, via protein-protein interactions, some of which engage the carbohydrate-binding groove. When ligands bind within this site, conformational rearrangements are induced and information on unliganded galectin-3 is therefore valuable for structure-based drug design. Removal of cocrystallized lactose from the human galectin-3 carbohydrate-recognition domain was achieved via crystal soaking, but took weeks despite low affinity. Pre-soaking to remove lactose enabled the subsequent binding of cryoprotectant glycerol, whereas when the lactose was not removed a priori the glycerol could not displace it in the short cryosoaking time frame. This slow diffusion of lactose out of the crystals contrasts with the entrance of glycerol, which takes place within minutes. The importance of the removal of incumbent ligands prior to attempts to introduce alternative ligands is indicated, even for proteins exhibiting low affinity for ligands, and has significance for ligand exchange in structure-based drug design.
PubMed: 17327679
DOI: 10.1107/S090744490605270X
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.35 Å)
構造検証レポート
Validation report summary of 2nn8
検証レポート(詳細版)ダウンロードをダウンロード

239149

件を2025-07-23に公開中

PDB statisticsPDBj update infoContact PDBjnumon